ResMed
446 hedge funds and large institutions have $8.89B invested in ResMed in 2018 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 137 increasing their positions, 164 reducing their positions, and 31 closing their positions.
119% more first-time investments, than exits
New positions opened: 68 | Existing positions closed: 31
29% more call options, than puts
Call options by funds: $13.6M | Put options by funds: $10.6M
17% more capital invested
Capital invested by funds: $7.57B → $8.89B (+$1.32B)
7% more funds holding
Funds holding: 416 → 446 (+30)
0.17% more ownership
Funds ownership: 62.98% → 63.15% (+0.17%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
16% less repeat investments, than reductions
Existing positions increased: 137 | Existing positions reduced: 164
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$71.8M |
| 2 |
JP Morgan Chase
New York
|
+$60.3M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$30.8M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$19.1M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$18.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MICM
Matthews International Capital Management
San Francisco,
California
|
-$61.7M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$48.7M |
| 3 |
State Street
Boston,
Massachusetts
|
-$22.4M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$16.4M |
| 5 |
Renaissance Technologies
New York
|
-$9.54M |
RMD Hedge Fund Activity: Q1 2018 in Review
446 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q1 2018, worth a combined $8.89B — up 17% from $7.57B a quarter earlier.
Buyers outnumbered sellers: 68 funds opened new RMD positions and 31 closed out — a net gain of 37 holders — while 137 added to existing stakes and 164 trimmed.
The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was Matthews International Capital Management, exiting entirely with an estimated $61.7M sold.
- 446 institutional investors held ResMed (RMD) as of Q1 2018, up from 416 in Q4 2017.
- Funds reported $8.89B of ResMed stock for Q1 2018, up 17% quarter-over-quarter.
- 68 funds opened new ResMed positions in Q1 2018 and 31 closed out, a net change of +37 holders.
- The largest ResMed buyer in Q1 2018 was Millennium Management, an estimated $71.8M added.
- The largest ResMed seller in Q1 2018 was Matthews International Capital Management, an estimated $61.7M sold.
Based on aggregated 13F filings for Q1 2018.